Breakin News
Tuesday, September 14, 2010
Arna Pharmaceuticals Inc
Arna Pharmaceuticals Inc
Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is lower after Barclays cut cutting of biotechnology to “underweight” on Quebec Concern lorcaserin Arena will be approved by the FDA.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment